Elekta stock gains on a €100 million EIB loan
Published on 08/31/2026 at 11:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elekta stock is drawing attention after the company secured a €100 million European Investment Bank loan on August 31, 2026, a financing package worth just over SEK 1.1 billion. The move adds a concrete funding milestone for the Swedish medical technology group and gives investors a fresh date-stamped catalyst.
Funding boost
According to a report on the loan, the financing is tied to development work on cancer treatments. That matters because the headline number is specific - €100 million - and the transaction was reported on August 31, 2026, which keeps the focus on current company news rather than a historical filing.
Marketscreener also said the loan is equivalent to just over SEK 1.1 billion, giving the deal a second currency anchor. For Elekta, that scale is material against a market value of SEK 21.62 billion cited in a same-day company overview.
What investors can measure
The same overview described Elekta as a medical technology company serving cancer and brain-disorder treatment across the Americas, Europe, the Middle East, Africa and Asia Pacific. It also said recent earnings showed net income of SEK 264 million, while sales were slightly lower, which gives the loan news a clearer operating backdrop.
The comparison is straightforward: net income was positive at SEK 264 million even as sales eased. That combination suggests the market is weighing financing support against the latest sales trend rather than treating the loan as a stand-alone event.
Go deeper
The product side of Elekta's business remains centered on oncology systems and treatment planning software, which are the kinds of tools that fit the company’s stated cancer-treatment focus. The new financing points back to that core franchise rather than to a one-off side project.
Stock level
Elekta shares trade on Nasdaq Stockholm in SEK, and the latest market snapshot in the result set puts the company at a SEK 21.62 billion market cap. The loan news gives the stock a clear near-term reference point as the market rechecks funding, sales and profitability together.
Company
Company: Elekta AB
ISIN: SE0000163628
Ticker: EKTAB
Exchange: Nasdaq Stockholm
Market cap: SEK 21.62 billion
Sector / Industry: Health Care / Health Care Equipment & Supplies
Index membership: Nasdaq Stockholm Large Cap
